T. Rowe Price Associates, Inc. 13D and 13G filings for Legend Biotech Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 1:22 pm Purchase | 2024-09-30 | 13G | Legend Biotech Corporation LEGN | T. Rowe Price Associates, Inc. | 11,165,584 6.100% | 357,368 (+3.31%) | Filing |
| 2024-02-14 10:03 am Purchase | 2023-12-31 | 13G | Legend Biotech Corporation LEGN | T. Rowe Price Associates, Inc. | 10,808,216 5.900% | 10,808,216 (New Position) | Filing |